116 related articles for article (PubMed ID: 1802683)
1. Insulin-stimulated glucose uptake and fasting blood glucose.
Okamoto M; Okamoto M; Nishimura H; Kosaki A; Kono S; Inoue G; Maeda I; Kubota M; Hayashi T; Kuzuya H
Endocrinol Jpn; 1991 Aug; 38(4):421-7. PubMed ID: 1802683
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM.
Nolan JJ; Ludvik B; Baloga J; Reichart D; Olefsky JM
Diabetes; 1997 Jun; 46(6):994-1000. PubMed ID: 9166671
[TBL] [Abstract][Full Text] [Related]
3. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
[TBL] [Abstract][Full Text] [Related]
4. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
Vaag A; Alford F; Beck-Nielsen H
Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
[TBL] [Abstract][Full Text] [Related]
5. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
[TBL] [Abstract][Full Text] [Related]
6. Metabolic defects in persistent impaired glucose tolerance are related to the family history of non-insulin-dependent diabetes mellitus.
Niskanen L; Sarlund H; Laakso M
Metabolism; 1995 Aug; 44(8):1099-104. PubMed ID: 7637652
[TBL] [Abstract][Full Text] [Related]
7. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
[TBL] [Abstract][Full Text] [Related]
8. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
[TBL] [Abstract][Full Text] [Related]
10. Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport.
Ciaraldi TP; Molina JM; Olefsky JM
J Clin Endocrinol Metab; 1991 Apr; 72(4):876-82. PubMed ID: 2005215
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
[TBL] [Abstract][Full Text] [Related]
12. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization.
Hollenbeck CB; Chen YD; Reaven GM
Diabetes; 1984 Jul; 33(7):622-6. PubMed ID: 6376218
[TBL] [Abstract][Full Text] [Related]
14. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.
Féry F; Balasse EO
Diabetes; 1994 Dec; 43(12):1418-25. PubMed ID: 7958493
[TBL] [Abstract][Full Text] [Related]
15. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
[TBL] [Abstract][Full Text] [Related]
16. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
Luzi L; Petrides AS; De Fronzo RA
Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
[TBL] [Abstract][Full Text] [Related]
17. Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy.
Baron AD; Laakso M; Brechtel G; Edelman SV
J Clin Invest; 1991 Apr; 87(4):1186-94. PubMed ID: 2010535
[TBL] [Abstract][Full Text] [Related]
18. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
[TBL] [Abstract][Full Text] [Related]
19. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A
Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055
[TBL] [Abstract][Full Text] [Related]
20. Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus.
Mandarino LJ; Consoli A; Kelley DE; Reilly JJ; Nurjhan N
J Clin Endocrinol Metab; 1990 Dec; 71(6):1544-51. PubMed ID: 2121778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
